BioPharma Credit PLC (BPCP.L) LSE

Currency In GBp

AD

Valuation

Market Cap776.26M
Enterprise Value763.69M
P/E Ratio8.59
PEG Ratio0.83
Price/Sales Ratio7.83
Price/Book Ratio0.97
Enterprise/Revenue7.34
Enterprise/EBITDA7.92

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.93
Operating Margin0.93
AD

Management Effectiveness

Return On Assets0.11
Return On Equity0.11

Income Statement

Revenue140.06M
Revenue/Share0.12
Gross Profit114.36M
EBITDA129.73M
Net Income129.73M
Diluted EPS0.11

Balance Sheet

Total Cash68.71M
Total Cash/Share0.06
Total Debt0
Total Debt/Equity0
Current Ratio26.43
Book Value Per Share1.01

Price History

52-Week Change7.61
52-Week High74.97
52-Week Low0.64
Moving Average 50 Days0.73
Moving Average 200 Days0.7

Statistics

Average Volume14,700
Shares Outstanding1.14B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.1
Trailing Annual Dividend Yield10.17
Payout Ratio0.86
Last Split FactorN/A
Last Split DateN/A
AD